Funder
National Institute of Allergy and Infectious Diseases
Reference43 articles.
1. AR101 Oral immunotherapy for peanut allergy;Vickery;N Engl J Med,2018
2. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy;Begin;Allergy Asthma Clin Immunol,2014
3. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial;Hourihane;Lancet Child Adolesc Health,2020
4. Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial;Bird;J Allergy Clin Immunol Pract,2018
5. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study;Jones;Lancet,2022
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献